Skip to content

Drug interactions

Fostamatinib + Irinotecan

Severity: Moderate

Fostamatinib and Irinotecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fostamatinib's active metabolite R406 inhibits P-glycoprotein and may increase exposure to irinotecan and SN-38, which are P-gp substrates. This could intensify myelosuppression and diarrhea. Clinical data on this pair are lacking.

What this interaction means in plain words

Fostamatinib and Irinotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fostamatinib belongs to Oncology; Irinotecan belongs to Oncology.

Evidence level: Low

Why it happens

R406 inhibits intestinal and other P-gp efflux, increasing substrate absorption and exposure.

What to do

Monitor blood counts and gastrointestinal toxicity, and reduce the irinotecan dose if toxicity occurs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fostamatinib and Irinotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fostamatinib with Irinotecan?

MediHelp rates the interaction as moderate. Fostamatinib and Irinotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fostamatinib's active metabolite R406 inhibits P-glycoprotein and may increase exposure to irinotecan and SN-38, which are P-gp substrates. This could intensify myelosuppression and diarrhea. Clinical data on this pair are lacking.

How serious is the interaction between Fostamatinib and Irinotecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and gastrointestinal toxicity, and reduce the irinotecan dose if toxicity occurs.

What other medicines interact with Irinotecan?

MediHelp also lists interactions of Irinotecan with, for example, Clozapine, Sacituzumab govitecan, Adenovirus types 4 and 7 live. The full list is on the Irinotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in